Hyoscyamine
- Product NDC
- 51525-0115
- 11-digit product format
- 515250115
- Labeler code
- 51525
- Product ID
- 51525-0115_0522d7a7-0349-48e2-85d9-827963cc4986
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- hyoscyamine sulfate
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2016-05-01
- Substance
- HYOSCYAMINE SULFATE
- Active strength
- .375 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Hyoscyamine
- Brand name suffix
- ER
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| HYOSCYAMINE SULFATE | .375 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | F2R8V82B84 |
| Rxcui | 1046770 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51525-0115-1 | HyoscyamineER | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51525-0115 | HYOSCYAMINE ER (HYOSCYAMINE SULFATE) TABLET, EXTENDED RELEASE [WALLACE PHARMACEUTICALS INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20181219_5bbce8c0-a9c9-45b9-8457-1542bd3d9449.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51525-0115-1 | 51525011501 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51525-0115-1) | 2016-05-01 | 0000-00-00 | No | No | Current |